Funded Local Who is raising money in your own backyard?

VANCOUVER, British Columbia--(BUSINESS WIRE)--Response Biomedical Corporation (TSX: RBM, OTCBB: RPBF) announced today the signing of a subscription agreement providing for the sale of C$8 million of its common shares to funds affiliated with OrbiMed Advisors, LLC. The closing of the private placement is subject to receipt of all necessary regulatory approvals, including the approval of the Toronto Stock Exchange (“TSX”) and the shareholders of the Company.

Proceeds will enable faster market availability of new high capacity broadband services

April 7, 2010 (Vancouver, BC) – Radiant Communications Corp. (the “Corporation”) (TSX-V: RCN), Canada's leading supplier of Broadband Solutions for Business™, today announced two non-brokered private placements that will increase the funds available to invest in new technologies and markets.

WebTech Wireless Inc. (TSX: WEW) (“WebTech” or the “Company”), a leading provider of vehicle fleet location-based services (LBS) and telematics technology, is pleased to announce details of its previously announced, non-brokered private placement to certain members of senior management and the Company’s Board of Directors (the “Private Placement”). Pursuant to the Private Placement, the Company intends to issue 833,333 common shares at a price of $0.60 per common share to certain members of senior management and the Company’s Board of Directors for gross proceeds of $500,000.

QHR Technologies Inc. ("QHR" or the "Company") (TSX VENTURE:QHR) is pleased that the TSX Venture Exchange has accepted QHR's $1,040,000 non-brokered private placement for filing documentation on March 22, 2010. The Company announced the private placement on March 10, 2010 and completed the private placement on March 17, 2010.

WebTech Wireless Inc. (TSX:WEW), a leading provider of vehicle fleet location-based services (LBS) and telematics technology, today reported that it intends to proceed with a non-brokered private placement to certain members of senior management and members of the board of directors for up to $500,000 worth of common shares to be issued at market price after the close of the market on March 25, 2010.

CardioComm Solutions, Inc. (TSX-V: EKG) (“CardioComm” or the “Company”) today announced that it will be conducting a non-brokered private placement equity financing under which it will issue 10,000,000 units at a price of $0.05 per unit for gross proceeds of $500,000. Each unit will be comprised of one common share of the Company and one common share purchase warrant exercisable for two years for an additional share at a price of $0.10. The subscriber under the financing will be MD Primer Inc., which is a control person of the Company.

GreenAngel Energy Corporation (“GreenAngel”) (TSX-V: GAE) reports that Delaware Power Systems Inc (“DPS”) and Light-Based Technologies Inc. (“LBT”), two of its investee companies have closed financing rounds totaling $6 million dollars.

GreenAngel Energy Corporation (“GreenAngel”) (TSX-V: GAE) has entered into a Memorandum of Understanding (“MOU”) with Rapid Electric Vehicles Inc. (“REV”) to raise up to $5 million in several tranches during 2010.

Neovasc Inc. (TSXV: NVC) today announced that it has completed the first tranche of a previously announced non-brokered private placement of approximately 7.4 million units at the price of $0.27 per unit for aggregate gross proceeds of up to $2.0 million. The proceeds of the offering will be used primarily to fund the COSIRA trial – a multi-center clinical trial intended to demonstrate the safety and efficacy of the company’s Reducer™ product for treating refractory angina.

International Bio Recovery Corporation ("IBR") (TSX-V: IBR.V) is pleased to announce that it has closed a non-brokered private placement of 22,851,499 units at $0.10. Each unit consists of one common share and one share purchase warrant exercisable at $0.125 for 2 years; the warrants will contain provisions that a) they cannot be exercised until four months after closing, and b) they must be exercised within 30 days of notice from IBR that the closing price of IBR's shares has been $0.25 per share for 20 consecutive trading days.